EUVIMEDEUVIMED entdecken
Crossref

Quality by design-based development and in vitro evaluation of dual release tablet of etoricoxib and thiocolchicoside: A novel chronotherapeutic approach for arthritis pain management

Anchal Sharma, Supriya Singh, Geetanjali Saini, Sanjay Sharma, Bhupendra Singh, Deepak Choudhary

Annales Pharmaceutiques Françaises · 2024

DOI: 10.1016/j.pharma.2024.07.004 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Annales Pharmaceutiques Françaises, 2024. Verfasst von Anchal Sharma und 5 weiteren Autor:innen. Beteiligte Einrichtung: Shiva Institute of Pharmacy, Bilaspur 174004, India. Hauptthemen laut MEDLINE: Etoricoxib, Colchicine, Tablets, Delayed-Action Preparations. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 28 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE: The traditional drug delivery system is not much effective when treating chronopathological diseases like arthritis. Consequently, there is a gap in the market for a delivery system that can provide an explicit treatment following the chronopharmacology of this disorder. The present study is based on the objective to develop Eudragit coated dual release bilayer tablet designed by the quality by design (QbD) and based on the chronotherapeutic approach. The dual release tablet contained an immediate release layer of etoricoxib and a sustained release layer of thiocolchicoside. MATERIAL AND METHOD: The quality target product profile (QTTP) of the formulation was established along with critical quality attributes (CQA). The optimization of the dual release layer was done using a three-level, three-factor Box-Behnken design. A total of thirteen formulations of etoricoxib (ET1-ET13) and thiocolchicoside (TH1-TH13) were developed based on the design composition of etoricoxib, sodium starch glycolate and sodium bicarbonate for the immediate release (IR) layer and thiocolchicoside, HPMC E5 LV and magnesium stearate for the sustained release (SR) layer respectively. The developed dual release layers were compressed to form a bilayer tablet. The bilayer tablets were further coated with pH-dependent polymer Eudragit S-100 to avoid drug release in upper GIT. The initial characterization and drug-excipient interaction studies were performed initially using infra-red (IR) spectroscopy and X-ray diffraction studies (XRD). Formulations showing good micrometric properties, disintegration and drug release were selected for final compression of bilayer tablets. RESULT: Formulation ET13 showed the fastest drug release (88%) at 15minutes and quick disintegration time (21s). The sustained release thiocolchicoside tablet layer (TH1-TH13) had a hardness that varied from 4.01 to 4.45kg/cm2. Formulation TH12 had the highest hardness, whereas TH6 showed the lowest hardness. The sustained release layer showing 97.63% of drug release after 8hours was selected for the compression to bilayer tablet. The developed dual layer tablets were investigated for quality parameters like hardness, percentage friability, weight variation, disintegration and dissolution. CONCLUSION: A high level of patient compliance is ensured through the current design as the patient does not need to get out of bed at night to take the medication.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

EtoricoxibColchicineTabletsDelayed-Action PreparationsDrug LiberationDrug ChronotherapyPain ManagementChemistry, PharmaceuticalExcipientsPain

Stichwörter der Autor:innen

ChronotherapeuticsChronothérapeutiqueDouble libérationDual releaseEtoricoxibQbDThiocolchicosideÉtoricoxib

Substanzen

thiocolchicosideEtoricoxibColchicineTabletsDelayed-Action PreparationsExcipients

Autor:innen und Institutionen

  • Shiva Institute of Pharmacy, Bilaspur 174004, India.
  • Department of Pharmaceutical Sciences, Mohanlal Sukhadia University, Udaipur, Rajasthan 313001, India.
  • College of Pharmacy, Teerthankar Mahaveer University, Moradabad, Utter Pradesh 244001, India.
  • SVKM'S NMIMS, Shobhaben Pratapbhai Patel School of Pharmacy and Technology Management, Mumbai 400056, India.
  • College of Pharmacy, Teerthankar Mahaveer University, Moradabad, Utter Pradesh 244001, India. Electronic address: bhupendra.pharmacy@tmu.ac.in.
  • Department of Pharmaceutical Sciences, Mohanlal Sukhadia University, Udaipur, Rajasthan 313001, India. Electronic address: deepakseervi@gmail.com.

Zitieren

APA

Sharma, A., Singh, S., Saini, G., Sharma, S., Singh, B., & Choudhary, D. (2024). Quality by design-based development and in vitro evaluation of dual release tablet of etoricoxib and thiocolchicoside: A novel chronotherapeutic approach for arthritis pain management. Annales Pharmaceutiques Françaises. https://doi.org/10.1016/j.pharma.2024.07.004

Vancouver

Sharma A, Singh S, Saini G, Sharma S, Singh B, Choudhary D. Quality by design-based development and in vitro evaluation of dual release tablet of etoricoxib and thiocolchicoside: A novel chronotherapeutic approach for arthritis pain management. Annales Pharmaceutiques Françaises. 2024. doi:10.1016/j.pharma.2024.07.004

BibTeX
@article{Sharma2024,
  author = {Sharma, Anchal and Singh, Supriya and Saini, Geetanjali and Sharma, Sanjay and Singh, Bhupendra and Choudhary, Deepak},
  title = {Quality by design-based development and in vitro evaluation of dual release tablet of etoricoxib and thiocolchicoside: A novel chronotherapeutic approach for arthritis pain management},
  journal = {Annales Pharmaceutiques Françaises},
  year = {2024},
  doi = {10.1016/j.pharma.2024.07.004}
}
Kostenlos starten →